{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:40:29Z","timestamp":1791646829055,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jaad.2015.08.052","type":"journal-article","created":{"date-parts":[[2015,9,27]],"date-time":"2015-09-27T09:41:58Z","timestamp":1443346918000},"page":"998-1005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)"],"prefix":"10.1016","volume":"73","author":[{"given":"Schapoor","family":"Hessam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Gambichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk G.","family":"Bechara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2015.08.052_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jaad.2015.08.052_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0007-1226(03)00177-2","article-title":"Hidradenitis suppurativa: pathogenesis and management","volume":"56","author":"Slade","year":"2003","journal-title":"Br J Plast Surg"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2015.08.052_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.052_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2015.08.052_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-4632.2004.02536.x","article-title":"\u201cHidradenitis suppurativa\u201d is acne inversa! An appeal to (finally) abandon a misnomer","volume":"44","author":"Sellheyer","year":"2005","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.052_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.08.052_bib7","series-title":"Roenigk and Roenigk's dermatologic surgery: principles and practice","first-page":"633","article-title":"Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach","author":"Hurley","year":"1996"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.052_bib8","first-page":"432","article-title":"Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging","volume":"14","author":"Matusiak","year":"2009","journal-title":"Biomark Biochem Indic Expo Response Susceptibility Chem"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.052_bib9","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/bjd.12234","article-title":"Myeloid marker S100A8\/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?","volume":"168","author":"Wieland","year":"2013","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.052_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2340\/00015555-2061","article-title":"Chitinase-3-like Protein 1 (YKL-40): novel biomarker of hidradenitis suppurativa disease activity?","volume":"95","author":"Matusiak","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2015.08.052_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2015.08.052_bib12","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.052_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2230.1996.tb00145.x","article-title":"Hidradenitis suppurativa\u2013characteristics and consequences","volume":"21","author":"Jemec","year":"1996","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2015.08.052_bib14","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/jdv.12952","article-title":"Surgery under general anesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients","volume":"29","author":"Blok","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.052_bib15","first-page":"165","article-title":"Hidradenitis suppurativa: a disease with male predominance in Tunisia","volume":"18","author":"Mebazaa","year":"2009","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.052_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2796.2008.02015.x","article-title":"C-reactive protein and coronary heart disease: a critical review","volume":"264","author":"Casas","year":"2008","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.jaad.2015.08.052_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12632","article-title":"Increased serum C-reactive protein level in Japanese patients of psoriasis with cardio- and cerebrovascular disease","volume":"41","author":"Takahashi","year":"2014","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.08.052_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1155\/2015\/389548","article-title":"Biomarkers as potential treatment targets in inflammatory bowel disease: a systematic review","volume":"29","author":"Murdoch","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2015.08.052_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MIB.0000000000000516","article-title":"Silent Crohn's disease: asymptomatic patients with elevated C-reactive protein are at risk for subsequent hospitalization","author":"Click","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2015.08.052_bib20","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2015.08.052_bib21","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0195-668X(03)00260-4","article-title":"Independent association of various smoking characteristics with markers of systemic inflammation in men: results from a representative sample of the general population (MONICA Augsburg survey 1994\/95)","volume":"24","author":"Fr\u00f6hlich","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaad.2015.08.052_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/00039896.1973.10666241","article-title":"Smoking habits and the leukocyte count","volume":"26","author":"Friedman","year":"1973","journal-title":"Arch Environ Health"},{"issue":"8","key":"10.1016\/j.jaad.2015.08.052_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/thx.2003.012468","article-title":"Acute effects of cigarette smoke on inflammation and oxidative stress: a review","volume":"59","author":"van der Vaart","year":"2004","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.jaad.2015.08.052_bib24","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2015.08.052_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2010.02.017","article-title":"Relation of C-reactive protein to abdominal adiposity","volume":"106","author":"Brooks","year":"2010","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.jaad.2015.08.052_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2340\/00015555-1025","article-title":"Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers","volume":"91","author":"Delage","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2015.08.052_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2015.08.052_bib28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1365-4632.2010.04638.x","article-title":"Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy","volume":"49","author":"Arenbergerova","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2015.08.052_bib29","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/bjd.13122","article-title":"Association of hidradenitis suppurativa disease severity with increased risk\u00a0for systemic comorbidities","volume":"171","author":"Crowley","year":"2014","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.08.052_bib30","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumor necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.08.052_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2133.2011.10643.x","article-title":"Alterations in leukocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions","volume":"166","author":"van der Zee","year":"2012","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215021234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215021234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:35:49Z","timestamp":1759271749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215021234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0190962215021234"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.08.052","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}